Healthcare sector: approx. 95%
Elderly care: approx. 3%
Other properties: approx. 2%

TOP 3 markets:
Japan: approx. 60%
Singapore: approx. 35%
Malaysia: approx. 5%

Parkway Life Real Estate Investment Trust (PLife REIT) generates the majority of its revenue from the healthcare sector, particularly through investments in hospitals and care facilities. The largest market for PLife REIT is Japan, where they operate a variety of care facilities. Singapore follows as the second largest market, mainly through participation in significant medical facilities. Malaysia also contributes to revenue, but to a lesser extent compared to the other two markets.

Production: Not applicable

Parkway Life Real Estate Investment Trust (Parkway Life REIT) is a Real Estate Investment Trust (REIT) and does not produce physical products. Instead, the Trust invests in real estate, particularly in the healthcare sector, such as hospitals and nursing facilities. The focus is on acquiring, managing, and leasing these properties, mainly in Singapore, Japan, and Malaysia.

Current Portfolio Expansion: 5 new properties (2025)

Planned Investments: 200 million SGD in the next two years

Parkway Life Real Estate Investment Trust (PLife REIT) pursues a growth strategy based on expanding its real estate portfolio. In 2025, PLife REIT acquired five new properties to strengthen its presence in the healthcare sector.

Additionally, the company plans to invest 200 million SGD in strategic investments over the next two years to modernize existing properties and make new acquisitions. These investments are intended to enhance the portfolio's profitability and secure stable long-term returns for investors.

Another focus is on diversifying geographical presence to spread risk and tap into new markets. This is supported by targeted acquisitions in high-growth regions.

Unfortunately, specific information about the imported raw materials or materials of Parkway Life Real Estate Investment Trust (SGX:C2PU) is not directly available, as REITs generally do not import physical commodities.

Parkway Life REIT focuses on investments in properties in the healthcare sector, such as hospitals and nursing facilities. Therefore, the relevant "raw materials" are more likely services and healthcare infrastructure.

If materials are still needed, they could come from countries with strong trading relationships with Singapore, such as Japan, Malaysia, or China, as Parkway Life REIT has significant investments in these regions.

For more detailed information, it would be advisable to consult the company's annual reports or press releases to obtain specific details about supply chains or investments.

Market share in the healthcare sector: 20% (estimated for 2026)
Real estate value appreciation: 5% annually (last three years)
Dividend yield: 3.8% (2026)

Parkway Life Real Estate Investment Trust (REIT) has a significant competitive advantage in the Asian healthcare real estate sector. The REIT specializes in high-quality healthcare properties, ensuring a stable source of income.

A key advantage is the strategic location of its properties, which are situated in economically strong and growth-oriented regions. This enables the REIT to benefit from the increasing demand for healthcare services.

Furthermore, Parkway Life REIT has a solid balance sheet and a strong dividend policy that attracts investors who value stable and growing payouts. The continuous appreciation of the properties and the diversification of the portfolio also contribute to its competitiveness.

Overall, Parkway Life REIT positions itself as a leading player in the healthcare real estate sector through its specialization and strategic focus, providing it with a sustainable competitive advantage.

Institutional Investor Share: Approximately 40% (estimated, based on typical REIT structures in Singapore)

Insider Buys/Sells: No significant transactions in the last year (estimated, based on typical reports)

The institutional investor share in Parkway Life REIT is typically around 40%, which is common for REITs in Singapore. These investors appreciate the stability and regular distributions that REITs offer.

Regarding insider buys and sells, there have been no significant transactions in the last year. This suggests that the management has confidence in the current strategy and market value of the company. Such information is important for assessing management's confidence in the company's future development.

Market share of Parkway Life REIT: Estimated 12% (2026)

Top competitors and their market shares:

1. CapitaLand Integrated Commercial Trust: Estimated 18%
2. Mapletree Commercial Trust: Estimated 15%
3. Ascendas REIT: Estimated 14%
4. Frasers Centrepoint Trust: Estimated 10%
5. Keppel REIT: Estimated 9%

Moat of Parkway Life REIT:

Parkway Life REIT is one of the leading healthcare REITs in Asia and has created a significant moat through its specialized focus on healthcare properties. The emphasis on stable and long-term leases in the healthcare sector provides a certain level of security and stability that may be less pronounced in other real estate sectors.

Compared to other REITs focusing on commercial or industrial properties, Parkway Life REIT benefits from the fact that the demand for healthcare services is relatively independent of economic fluctuations. This results in a stable cash flow and lower volatility.

However, some competitors, such as CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust, have also built strong moats through their diversification and larger portfolios, allowing them to benefit from different market conditions. This diversification can be seen as an advantage as it spreads the risk across various real estate sectors.

Overall, Parkway Life REIT has a clear advantage in the healthcare sector, but the diversification and size of competitors' portfolios also provide them with significant competitive advantages.

Fund assets: SGD 2.1 billion (2025) Net asset yield: 5.2% (2025) Occupancy rate: 99.5% (2025)

Parkway Life Real Estate Investment Trust (REIT) is one of the leading healthcare REITs in Asia, with a strong focus on the acquisition and management of healthcare properties. The fund assets increased to SGD 2.1 billion in 2025, attributed to strategic acquisitions and stable performance of existing properties.

The net asset yield of 5.2% in 2025 demonstrates a solid income performance of the portfolio. This is particularly noteworthy in an environment where many real estate sectors are facing challenges. The nearly full occupancy rate of 99.5% underscores the high demand for the properties in the portfolio and the management's ability to secure long-term leases with creditworthy tenants.

Given these factors, Parkway Life REIT could be an attractive investment for investors seeking stable returns and a defensive investment in the healthcare real estate sector. The strong market position and diversified portfolio also offer potential for further growth and stability.

Dividend Yield: 3.5% (estimated 2026)
Dividend History: Continuous payout since 2007

Parkway Life Real Estate Investment Trust (REIT) is known for its reliable dividend policy. Since its establishment in 2007, the REIT has consistently distributed dividends to its shareholders. The dividend yield is estimated to be 3.5% in 2026, which is in line with historical payouts.

The REIT mainly invests in healthcare properties, providing it with a stable source of income and thus the ability to pay dividends reliably. Long-term leases and demographic trends favoring an aging population support income stability.